N-P-TOSYL-L-LYSINE METHYL ESTER HYDROCHLORIDE

Suppliers

Names

[ CAS No. ]:
5266-48-8

[ Name ]:
N-P-TOSYL-L-LYSINE METHYL ESTER HYDROCHLORIDE

[Synonym ]:
N|A-p-Tosyl-L-lysine methyl ester hydrochloride
Nalpha-p-Tosyl-L-lysine methyl ester hydrochloride
N-(p-Toluenesulfonyl)-L-lysine methyl ester

Chemical & Physical Properties

[ Molecular Formula ]:
C14H23ClN2O4S

[ Molecular Weight ]:
350.86100

[ Exact Mass ]:
350.10700

[ PSA ]:
106.87000

[ LogP ]:
3.91790

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ RIDADR ]:
NONH for all modes of transport

[ HS Code ]:
2935009090

Customs

[ HS Code ]: 2935009090

[ Summary ]:
2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%

Articles

Amyloid beta 2-microglobulin is modified with N epsilon-(carboxymethyl)lysine in dialysis-related amyloidosis.

Kidney Int. 50 , 1303-1309, (1996)

Recent work from this laboratory revealed that advanced glycation end product was localized to amyloid deposits in patients with dialysis-related amyloidosis by immunohistochemistry using a monoclonal...

Effect of protease inhibitors on human monocyte IgG Fc receptor II. Evidence that serine esterase activity is essential for Fc gamma RII-mediated binding.

J. Immunol. 145(6) , 1890-6, (1990)

We have shown previously that certain proteases can modulate the affinity of human Fc gamma RII for IgG. To study whether proteolytic events not only increase FcR affinity, but are essential for Fc ga...

The mechanism of the inhibitory effect of protease inhibitors on platelet aggregation and cellular synthesis of prostaglandins. I. The effect on the release of arachidonic acid from phospholipids.

Thromb. Res. 20(5-6) , 587-98, (1980)


More Articles


Related Compounds

  • N-EPSILON-P-TOSYL-L-LYSINE ETHYL ESTER HYDROCHLORIDE
  • N-tosyl-N'-benzyloxycarbonyl-L-lysine methyl ester
  • TOS-ARG-OME.HCL
  • N-tosyllysine methyl ester
  • methyl (2S)-2,6-diaminohexanoate,hydrochloride
  • H-Lys(Fmoc)-OMe.HCl
  • 3,5-Diiodo-L-thyronine 4'-O-Sulfate
  • (R)-2-(((Benzyloxy)carbonyl)amino)-5-(N'-((2,2,5,7,8-pentamethylchroman-6-yl)sulfonyl)formohydrazonamido)pentanoic acid
  • (2S)-2-Hydrazino-3-(3-hydroxy-4-methoxyphenyl)-2-methylpropanoic acid
  • (E)-5-[3-[[(1,1-Dimethylethoxy)carbonyl]amino]phenyl]-2-penten-4-ynoic Acid Methyl Ester
  • (1r,3r)-3-(1H-pyrazol-1-yl)cyclobutane-1-carboxylic acid
  • (S)-9,10-Difluoro-3-methyl-2,3,5,6-tetrahydro-7,7-O-ethylidene-7H-pyrido[1,2,3-de]-1,4-benzoxazin-7,7-diol
  • 3-Chloro Dasatinib
  • 2-(5-Amino-1-tert-butyl-4-cyano)methoxyphenyl
  • N-Benzyl-N-methyl-2-[N'-[3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl]ethanolamine]ethylamine
  • 3-Bromo-L-thyroxine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.